ArticleJMIR research protocols2026

Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.

Takenao Koseki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.